explore -WSS

explore

author：hotspot 2025-09-28 01:24:08 - browse：2729

The US Supreme Court silhouetted -- Abortion coverage from STAT — STEFANI REYNOLDS/AFP via Getty Images

WASHINGTON — The Supreme Court on Monday wrestled with a nationwide settlement with OxyContin maker Purdue Pharma that would shield members of the Sackler family who own the company from civil lawsuits over the toll of opioids.

The justices seemed by turns relucant to break up an exhaustively negotiated agreement, but also leery of somehow rewarding the Sacklers.

The agreement hammered out with state and local governments and victims would provide billions of dollars to combat the opioid epidemic. The Sacklers would contribute up to $6 billion and give up ownership of the company, but retain billions more. The company would emerge from bankruptcy as a different entity, with its profits used for treatment and prevention.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Apple is now the first public company to be valued at $3 trillion
Next article： CDC director unscathed in first congressional testimony

leisure time

WSS

WATCH: Why do fingernails fall off when they're damaged?

Death of patient in Alzheimer’s trial raises question of possible risks

Organ aging and disease risk measured by new blood test

Gene therapy has helped boys walk. Can scientists keep it that way?

With clinical trial data readouts, here's how to spot spin

Organ aging and disease risk measured by new blood test

entertainment

explore

hotspot

Walensky prepares to leave CDC — and Congress — behind

Disclosing genetic information: not as worrisome as once feared

How one medical school became remarkably diverse

Rep. Raul Ruiz on the physician shortage and more

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Fetal surgery at risk from Dobbs and new abortion restrictions

Hollywood unions extend contract negotiations for actors

Cloning humans is technically possible. It's curious no one has tried

Medicare details structure of new drug price negotiation program

Diagnostic tests are hitting their mathematical limits

hotspot

#NeedHerScience: shining a light on gender disparities in medicine

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

How to pay for weight loss drugs and save Medicare

ReNAgade cuts staff seven months after raising $300 million

Donald Trump's relentless attacks on special counsel Jack Smith

How to pay for weight loss drugs and save Medicare

focus

entertainment

leisure time

explore